新型冠状病毒肺炎(COVID-19)中医临床诊疗快速建议指南

标题: 新型冠状病毒肺炎(COVID-19)中医临床诊疗快速建议指南
title: A Rapid Advice Guideline of Traditional Chinese Medicine for Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19)
版本: 更新版
version: Updated
分类: 快速建议指南
classification: Rapid advice guideline
领域: 综合
field: Comprehensive guideline
国家和地区: 中国
Country and region: China
指南使用者: 发热门诊、急诊科、重症医学科、呼吸科、中医科、中西医结合科等诊治与护理COVID-19感染肺炎患者的广大医护、社区居民、公共卫生人员及研究者。
Guide users: The worldwide medical workers who are taking care of people with COVID-19 from such as fever clinics, emergency departments, critical care departments, respiratory departments, traditional Chinese medicine departments, and integrative tradtional Chinese a
证据分级方法:
Evidence grading method: 采用GRADE系统对证据体质量进行评价和分级。基于RCT的系统评价起始质量为高,考虑五个降级因素:偏倚风险、间接性、异质性、不精确性、发表偏倚;而基于观察性研究的起始质量为低,考虑大效应量、剂量-效应关系和负偏倚三个升级因素,最后分为高、中、低、极低四个证据等级,以证据总结表形式呈现。
制定单位: 中国中医药循证医学中心、中国中医科学院中医临床基础医学研究所
Formulating unit: China Center for Evidence-Based Traditional Chinese Medicine Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
注册时间: 2020-07-13
Registration time:
注册编号: IPGRP-2020CN033
Registration number:
指南制订的目的: 制订立足于患者、以临床问题为导向、循证医学为支托的高质量循证快速建议指南,以期系统有效地指导2019新型冠状病毒肺炎的中医临床诊疗实践,提升应对疫情能力,提高中医药在国际的使用程度和影响力。
Purpose of the guideline: To develop a patient-oriented evidence-based rapid advice guideline assisting the clinical practice of traditional Chinese medicine (TCM) for COVID-19, as well as enhancing the ability to cope with the disease, and improving the application and influence